119 related articles for article (PubMed ID: 648156)
1. Long-term contraception by a single silastic implant-D containing norethindrone acetate in women: a clinical evaluation.
Takkar D; Anandalaxmi PN; Chandra VL; Bhatnagar S; Yadav HS; Laumas KR; Hingorani V; Krishna U; Mandleker A; Purandare VN; Goel V; Adatia A; Virker KD
Contraception; 1978 Apr; 17(4):341-54. PubMed ID: 648156
[TBL] [Abstract][Full Text] [Related]
2. Long-term contraception by steroid releasing implants. VI. Serum concentrations of norethindrone in women bearing a single silastic implant releasing norethindrone acetate.
Hillier SG; Jha P; Griffiths K; Laumas KR
Contraception; 1977 Apr; 15(4):473-88. PubMed ID: 880821
[TBL] [Abstract][Full Text] [Related]
3. Effect of norethindrone acetate released from a single silastic implant on serum FSH, LH, progesterone and estradiol-17beta of women during first eight months of treatment.
Rahman SA; Jha P; Laumas V; Jain AK; Dileepkumar ; Takkar D; Hingorani V; Laumas KR
Contraception; 1977 Nov; 16(5):487-97. PubMed ID: 590011
[TBL] [Abstract][Full Text] [Related]
4. Long-term contraception by steroid-releasing implants. II. A preliminary report on long-term contraception by a single silastic implant containing norethindrone acetate (ENTA) in women.
Bhatnagar S; Srivastava UK; Takkar D; Chandra VL; Hingorani V; Laumas KR
Contraception; 1975 May; 11(5):505-21. PubMed ID: 1139938
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of norethindrone in women with a single silastic implant.
Goyal V; Joshi UM; Naik VK
Contraception; 1978 Apr; 17(4):375-82. PubMed ID: 648158
[TBL] [Abstract][Full Text] [Related]
6. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
7. Norethisterone contraceptive microspheres.
Rivera R; Alvarado G; Flores C; Aldaba S; Hernandez A
J Steroid Biochem; 1987; 27(4-6):1003-7. PubMed ID: 3695501
[TBL] [Abstract][Full Text] [Related]
8. Reduction of the oral contraceptive estrogen burden by alternate day estrogen administration.
Segre EJ; Henzl MR; Giner J; Scheel C; Bessler S
Contraception; 1975 Aug; 12(2):155-74. PubMed ID: 1139955
[TBL] [Abstract][Full Text] [Related]
9. Subdermal norethindrone pellets -- a method for contraception?
Odlind V; Moo-Young AJ; Gupta GN; Weiner E; Johansson ED
Contraception; 1979 Jun; 19(6):639-48. PubMed ID: 487813
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
[TBL] [Abstract][Full Text] [Related]
11. Liver function tests in patients on oral progestogens.
Engineer AD; Gupta V; Tandon P
J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
[TBL] [Abstract][Full Text] [Related]
12. Initial clinical studies of intravaginal rings containing norethindrone and norgestrel.
Mishell DR; lumkin M; Jackanicz T
Contraception; 1975 Sep; 12(3):253-60. PubMed ID: 1164845
[TBL] [Abstract][Full Text] [Related]
13. Contraceptive efficacy of norethindrone acetate (ENTA) implant: its release rate and fertility potential.
Shahani SM; Kulkarni PP; Laumas KR
J Obstet Gynaecol India; 1983 Feb; 33(1):16-20. PubMed ID: 12265592
[TBL] [Abstract][Full Text] [Related]
14. A clinical trial of norethisterone oenanthate (Norigest) injected every two months.
Howard G; Blair M; Chen JK; Fotherby K; Muggeridge J; Elder MG; Bye PG
Contraception; 1982 Apr; 25(4):333-40. PubMed ID: 7049569
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of norethindrone acetate in women after the insertion of a single subdermal implant releasing norethindrone acetate.
Singh H; Uniyal JP; Jha P; Takker D; Murguesan K; Hingorani V; Laumas KR
Acta Endocrinol (Copenh); 1982 Feb; 99(2):302-8. PubMed ID: 7058686
[TBL] [Abstract][Full Text] [Related]
16. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
[TBL] [Abstract][Full Text] [Related]
17. Use of Anovlar in gynaecological disorders and contraception.
Shahani SM; Chiklikar A
J Obstet Gynaecol India; 1968 Apr; 18(2):592-7. PubMed ID: 12331827
[TBL] [Abstract][Full Text] [Related]
18. Long-term administration of norethindrone in fertility control.
Rice-wray E; Schulz-contreras M; Guerrero I; Aranda-rosell A
JAMA; 1962 May; 180(5):355-8. PubMed ID: 12275504
[TBL] [Abstract][Full Text] [Related]
19. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
Furuhjelm M; Carlström K
Acta Obstet Gynecol Scand; 1977; 56(4):351-61. PubMed ID: 602703
[TBL] [Abstract][Full Text] [Related]
20. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
Kamal I; Zaki K; Rashad S
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
